Stem-cell-based Implant Feasible in Macular Degeneration Stem-cell-based Implant Feasible in Macular Degeneration
A bioengineered implant of human embryonic stem-cell-derived retinal pigment epithelium (RPE) may be of benefit in advanced dry age-related macular degeneration (AMD), according to preliminary research.Reuters Health Information
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Ophthalmology News Source Type: news
More News: Age-Related Macular Degeneration (AMD) | Opthalmology | Stem Cell Therapy | Stem Cells | Transplant Surgery | Transplants | Vitamin A